Tag: Fda warning

In 2010, the U.S. Food and Drug Administration (FDA) issued a boxed warning for the antiplatelet drug Plavix (clopidogrel) to alert healthcare professionals and patients about the reduced effectiveness in individuals who are genetically predisposed to being "poor metabolizers". This pharmacogenomic insight into the CYP2C19 warning on Plavix highlights how genetic variations can impact a drug's therapeutic benefit and increase the risk of serious cardiovascular events.

Prescriptions for semaglutide, the active ingredient in Ozempic, surged by 442% between 2021 and 2023 [1.6.1]. This guide addresses the critical question: **Is compounded semaglutide as effective as Ozempic?**

In a study of the FDA-approved drug Wegovy, participants lost up to 20% of their body weight over 68 weeks. This raises a critical question for many: is compounded semaglutide as effective as regular semaglutide, and is it a safe alternative?

While common side effects like nausea and diarrhea affect a significant portion of Mounjaro users, rarer but more serious adverse events can occur, highlighting the importance of understanding **what are the rare side effects of Mounjaro?**. For instance, clinical trials reported that a small percentage of individuals developed acute gallbladder disease, a risk that underscores the need for patient vigilance. This guide provides comprehensive information on these less common, but critical, safety considerations.

In December 2024, the U.S. Food and Drug Administration (FDA) added a Boxed Warning to the prescribing information for Veozah (fezolinetant) regarding the risk of serious liver injury. This warning was issued after a postmarketing case highlighted a rare but potentially serious hepatotoxicity event. It is crucial for patients and healthcare providers to understand that **does veozah cause liver problems** in rare instances, necessitating careful monitoring.

According to the FDA, in rare cases, the menopause drug Veozah (fezolinant) can cause serious liver injury and elevate liver blood test values. This critical safety information raises a serious concern for many users: **Does veozah raise liver enzymes?** The answer is yes, and understanding this risk is vital for anyone considering or currently taking the medication.

With an estimated 1.7 million people in the U.S. reporting kratom use in 2021, products containing the substance have surged in popularity [1.5.3]. A key question for consumers is: **how much kratom in Feel Free**, a popular tonic marketed for relaxation and focus?

In 2019, the FDA added a boxed warning to Ambien (zolpidem) and similar medications due to the risk of complex sleep behaviors. This warning draws attention to what is arguably the biggest side effect of Ambien, which involves users engaging in dangerous activities while not fully awake.

In the U.S., close to 38 million adults use prescription zolpidem (Ambien) for better sleep [1.2.3]. For some, this medication triggers strange behaviors, leading to the question: What is the Ambien walrus, and why is it a symbol for the drug's odd side effects? [1.2.3]

Paxlovid carries an FDA-issued boxed warning, the agency's most serious type, due to significant and potentially life-threatening drug interactions [1.2.4, 1.3.2]. If you're asking, **'What is the black box warning on Paxlovid?'**, it's crucial to understand these risks before starting treatment.